VALNEVA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.252 EUR | -3.67% |
|
+0.68% | -31.52% |
| Jul. 01 | Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine | MT |
| Jul. 01 | New semester, new state of mind |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VALNEVA | Other Biotechnology & Medical Research | -3.67% | +0.68% | -31.52% | -49.68% | +5.07% | 505M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- VLA Stock
- AYJ Stock
- Charts Valneva
- Comparison Chart
